Cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC) who have received prior sorafenib: results from the randomized phase 3 CELESTIAL trial


Waidmann O., Abou-Alfa G. K., Meyer T., Cheng A., El-Khoueiry A. B., Rimassa L., ...More

ONCOLOGY RESEARCH AND TREATMENT, vol.41, pp.254, 2018 (SCI-Expanded, Scopus)

  • Publication Type: Article / Abstract
  • Volume: 41
  • Publication Date: 2018
  • Journal Name: ONCOLOGY RESEARCH AND TREATMENT
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.254
  • Trakya University Affiliated: Yes